Horizon Pharma plc
Dec 22, 2016

Horizon Pharma plc to Present at the 35th Annual J.P. Morgan Healthcare Conference

DUBLIN, Ireland, Dec. 22, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it plans to present at the 35th Annual J.P. Morgan Healthcare ConferenceTimothy P. Walbert, chairman, president and chief executive officer, will present at 7:30 a.m. Pacific Time on January 10, 2017.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available following the event.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  Horizon Pharma markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

 

Contacts:



Investors:

Tina Ventura

Senior Vice President, Investor Relations

investor-relations@horizonpharma.com



U.S. Media:

Geoff Curtis

Senior Vice President, Corporate Communications

media@horizonpharma.com



Ireland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

Source: Horizon Pharma plc

News Provided by Acquire Media